Governance QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2026 am IST			5-day change	1st Jan Change
14.33 ^USD	-6.34%		+10.06%	-49.82%

07/05	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
07/05	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

Executive Committee: QuidelOrtho Corporation

Manager

Positions heldSince

Brian Blaser

61 year

Chief Executive Officer	06/05/2024
President	06/05/2024

Philip McLellan

57 year

Chief Operating Officer

15/11/2024

Sergio Gadaleta

General Counsel

07/07/2025

Lisa Hayes

Public Communications Contact	-
Sales & Marketing	-

Lee Bowman

Human Resources Officer

10/09/2024

Jonathan Siegrist

Chief Tech/Sci/R&D Officer

07/10/2024

Patrick Klein

Chief Administrative Officer

01/05/2022

Nathaniel Sisitsky

52 year

General Counsel

23/03/2026

Joseph Busky

58 year

Comptroller/Controller/Auditor	-
Director of Finance/CFO	-

Juliet C. Cunningham

Investor Relations Contact

Werner Kroll

69 year

Chief Tech/Sci/R&D Officer

Composition of the Board of Directors: QuidelOrtho Corporation

Director

CommitteesSince

Kenneth Buechler

72 year

Governance Committee	11/12/2022
Nominating Committee	11/12/2022

Evelyn Dilsaver

70 year

Governance Committee	18/12/2009
Nominating Committee	18/12/2009
Audit Committee Chair	11/05/2015
Compensation Committee	13/05/2024
HR Committee	01/08/2014
Audit Committee	13/05/2024
Governance Committee Chair	13/05/2024
Nominating Committee Chair	13/05/2024

Kenneth Widder

73 year

Audit Committee	02/10/2025
Governance Committee Chair	01/01/2014
Nominating Committee Chair	01/01/2014
Governance Committee	14/06/2023
Nominating Committee	14/06/2023

Ann Rhoads

60 year

Governance Committee	30/03/2012
Nominating Committee	30/03/2012
Audit Committee Chair

Matthew Strobeck

53 year

Audit Committee	01/01/2018
Governance Committee Chair	01/01/2012
Nominating Committee Chair	01/01/2012

R. Huennekens

61 year

Audit Committee	06/01/2025
Governance Committee	18/12/2019
Nominating Committee	18/12/2019

Joseph Wilkins

64 year

Compensation Committee	01/01/2021
Governance Committee	01/01/2021
Nominating Committee	01/01/2021

Brian Blaser

61 year

Audit Committee Chair

12/12/2022

Mary Polan

82 year

Compensation Committee

01/01/1993

Edward Michael

68 year

Compensation Committee Chair

01/01/2018

John Chiminski

62 year

Director/Board Member	06/12/2024
Independent Dir/Board Member	06/12/2024

Latest Appointments: QuidelOrtho Corporation

24/03	QuidelOrtho Corporation Announces Chief Legal Officer Changes	CI
14/02	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI
06/02	QuidelOrtho Corp Announces Departure of Director Matthew W. Strobeck	CI
20/25/20	Quidelortho welcomes Erich Wolff as EVP, strategy & corporate development	RE
20/25/20	QuidelOrtho Corporation Appoints Erich Wolff as Executive Vice President, Strategy & Corporate Development	CI
07/25/07	QuidelOrtho Corporation Announces Management Appointments	CI
07/25/07	Quidelortho strengthens leadership team with appointments of senior vice presidents for global quality and clinical & regulatory affairs	RE

More news

Former Officers and Directors: QuidelOrtho Corporation

Insider

Positions held

SinceUntil

Michelle Hodges

Compliance Officer	-	-
General Counsel	01/12/2020	23/03/2026
Corporate Secretary	-	23/03/2026

Robert Schmidt

Director/Board Member	01/01/2022	21/11/2024
Independent Dir/Board Member	01/01/2022	21/11/2024

James Prutow

Director/Board Member	28/11/2023	21/11/2024
Independent Dir/Board Member	28/11/2023	21/11/2024

Robert Bujarski

Chief Operating Officer	01/09/2020	15/11/2024
General Counsel	01/07/2005	01/09/2020
President	21/02/2024	06/05/2024

Michael Iskra

Chief Executive Officer	21/02/2024	06/05/2024
Corporate Officer/Principal	06/05/2024	15/11/2024

Louise Brandy

Chief Tech/Sci/R&D Officer

01/05/2024

Douglas Bryant

Director/Board Member	11/12/2022	21/02/2024
Chief Executive Officer	01/03/2009	21/02/2024
Chairman	01/03/2009	11/12/2022
President	11/12/2022	21/02/2024

Stephen Wise

Director/Board Member	01/01/2022	28/11/2023
Independent Dir/Board Member	01/01/2022	28/11/2023

Chris Smith

Director/Board Member

01/01/2022

31/08/2023

Karen Davies

Corporate Officer/Principal

Rhys de Callier

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	20
Female	4

Of which Executive Committee

Male	9
Female	2

Of which Directors

Male	9
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.

Employees

6,500

Sector

Advanced Medical Equipment & Technology

More about the company